Candriam SCA’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-57,201
| Closed | -$18.1M | – | 747 |
|
|
2023
Q4 | $18.1M | Sell |
57,201
-4,000
| -7% | -$1.27M | 0.13% | 170 |
|
|
2023
Q3 | $10.3M | Sell |
61,201
-6,000
| -9% | -$1.01M | 0.07% | 228 |
|
|
2023
Q2 | $14.6M | Hold |
67,201
| – | – | 0.11% | 198 |
|
|
2023
Q1 | $11.2M | Sell |
67,201
-15,000
| -18% | -$2.51M | 0.08% | 242 |
|
|
2022
Q4 | $16.2M | Hold |
82,201
| – | – | 0.11% | 193 |
|
|
2022
Q3 | $18.5M | Sell |
82,201
-6,526
| -7% | -$1.47M | 0.13% | 174 |
|
|
2022
Q2 | $11.2M | Buy |
88,727
+26,632
| +43% | +$3.37M | 0.09% | 210 |
|
|
2022
Q1 | $7.87M | Buy |
62,095
+43,039
| +226% | +$5.46M | 0.05% | 288 |
|
|
2021
Q4 | $2.5M | Sell |
19,056
-35,694
| -65% | -$4.68M | 0.02% | 502 |
|
|
2021
Q3 | $6.7M | Hold |
54,750
| – | – | 0.05% | 336 |
|
|
2021
Q2 | $6.24M | Buy |
+54,750
| New | +$6.24M | 0.04% | 364 |
|